Clinical Trial Update: Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study [Phase 2, Phase 3]

View source ↗

Summary

A randomized, single-blinded study evaluating convalescent plasma for COVID-19 (phases 2 and 3) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease
• Coronavirus Infection

Drugs mentioned

• Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: Universidad del Rosario | Conditions: Coronavirus, Coronavirus Infection | Phase 2, Phase 3 | Status: COMPLETED